DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Natco Pharma Limited — Board Meeting Intimation

NSE 2 hrs ago·4 Sept 2026, 1:36 pm

Natco Pharma

Natco Pharma has informed stock exchanges that its board will meet on September 9, 2026, to discuss plans for fund raising. This corporate action indicates the company is exploring options to bolster its financial position, potentially through debt, equity, or a mix of both. Such meetings often precede announcements regarding capital raising strategies or strategic initiatives.

For investors, this news signals that the company is actively managing its resources for future growth or to address specific business needs. While the exact purpose and size of the fund raising remain undisclosed, it generally reflects the management's confidence in the company's prospects. Investors should wait for the official announcement to understand the specific use of funds and the potential impact on the shareholding structure.